SCHEMBL7741401

SCHEMBL7741401

FCCCCn1c(CCl)nc2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
CXCR4 P61073 1/20 0.51
TP53 P04637 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MAPT P10636 3/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
GAA P10253 1/20 0.46
POLB P06746 2/20 0.46
TLR8 Q9NR97 2/20 0.46
LMNA P02545 2/20 0.45
TSHR P16473 2/20 0.45
USP2 O75604 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
RECQL P46063 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746045 0.85 SMN1; SMN2 (0.64) MEN1KMT2ACXCR4TP53SMN1; SMN2
SCHEMBL30184968 0.84 TLR8 (0.65) MEN1KMT2ATP53SMN1; SMN2MAPT
SCHEMBL23100601 0.81 SMN1; SMN2 (0.43) MEN1KMT2ATP53SMN1; SMN2MAPT
SCHEMBL15908540 0.81 AGTR1 (0.41) MEN1KMT2A
SCHEMBL9979855 0.81 BACE1 (0.49) MEN1KMT2ATP53SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL15301119 0.80 BACE1 (0.48) MEN1KMT2ATP53SMN1; SMN2MAPT
SCHEMBL3059715 0.80 MEN1 (0.64) MEN1KMT2ATP53SMN1; SMN2MAPT
SCHEMBL7230292 0.79 LMNA (0.57) MEN1KMT2ACXCR4TP53SMN1; SMN2
SCHEMBL102779 0.78 MEN1 (0.77) MEN1KMT2AMAPTGAAPOLB
SCHEMBL7740722 0.77 MEN1 (0.54) MEN1KMT2ACXCR4TP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed